Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

648
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
648
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.0K
Introduction to Hemostasis01:05

Introduction to Hemostasis

8.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.5K
Rh Blood Group01:19

Rh Blood Group

1.6K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

819
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
819
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

18
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
18

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two Perioperative Ketorolac Dosing Regimens After Cesarean Delivery and Opioid Use: A Randomized Controlled Trial.

O&G open·2026
Same author

Schlafen 11 as a prognostic and potentially predictive biomarker in soft tissue sarcoma: evidence from a real-world cohort.

Frontiers in oncology·2026
Same author

Immune cell clustering identifies a CD163⁺/CSF1R⁺ macrophage and neutrophil-enriched phenotype with distinct biological signatures and poor prognosis in angiosarcoma.

Oncoimmunology·2026
Same author

Categorizing Trends in Anesthesiology Residency Applicants' Research Portfolios and Impact on Matching: A Program-Level Study.

Anesthesia and analgesia·2026
Same author

c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors.

Cell reports. Medicine·2026
Same author

Assessing KAP of primary care physicians in Lebanon in screening for sudden cardiac arrest in youth.

Medicine·2026

Related Experiment Video

Updated: Aug 12, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K

Blood Product Replacement for Postpartum Hemorrhage.

Joe Eid1, David Stahl2

  • 1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center.

Clinical Obstetrics and Gynecology
|February 2, 2023
PubMed
Summary

For postpartum hemorrhage, consider blood product replacement after 1.5L blood loss. Standardized transfusion protocols, often using a 1:1:1 ratio, improve outcomes in massive hemorrhage cases.

More Related Videos

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.0K
Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats
09:47

Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats

Published on: June 14, 2024

647

Related Experiment Videos

Last Updated: Aug 12, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.0K
Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats
09:47

Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats

Published on: June 14, 2024

647

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Critical Care Medicine

Background:

  • Postpartum hemorrhage (PPH) remains a leading cause of maternal mortality worldwide.
  • Timely and appropriate management of severe PPH is crucial for patient survival and well-being.
  • Blood loss exceeding 1.5 liters or 25% of total blood volume necessitates intervention.

Purpose of the Study:

  • To outline the indications for blood product replacement in postpartum hemorrhage.
  • To review the efficacy of standardized transfusion protocols in managing massive obstetric hemorrhage.
  • To discuss the components and ratios of balanced transfusions and alternative therapies.

Main Methods:

  • Review of current clinical guidelines and evidence-based practices for managing postpartum hemorrhage.
  • Analysis of the components of standardized transfusion protocols, including ratios of blood products.
  • Identification of alternative hemostatic agents for specific clinical scenarios.

Main Results:

  • Blood product replacement should be considered when blood loss exceeds 1.5 L or 25% of estimated blood volume.
  • Standardized transfusion protocols significantly improve maternal morbidity and mortality in massive hemorrhage.
  • A balanced transfusion approach typically involves a 1:1:1 ratio of packed red blood cells, platelets, and fresh frozen plasma.

Conclusions:

  • Early consideration of blood product replacement is vital in significant postpartum hemorrhage.
  • Adherence to standardized transfusion protocols is associated with improved maternal outcomes.
  • While balanced transfusion is standard, individualized use of alternatives like cryoprecipitate and fibrinogen concentrate may be necessary.